Chapter 22: Fatty Acid Metabolism

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to the Deep Dive.

Our mission today is to take a massive foundational piece of

the entire system of how our bodies handle fat and really distill it down into a clear, understandable narrative.

That's the goal.

We are diving into fatty acid metabolism, the fuel economy of, well,

of molecular life.

It's the ultimate survival mechanism, you know, written in the language of enzymes.

When you look at this core chapter, the central theme becomes pretty obvious.

It's all about how the body developed these incredibly distinct, efficient, and rigorously controlled pathways for both storing energy and then retrieving it.

Two sides of the same coin.

Exactly.

And we're dealing with fatty acids, which, you know, structurally, they're quite simple, just a long hydrocarbon chain with a carboxylate group at the end.

But their metabolism reveals this fundamental principle, synthesis, which is building them up and degradation, breaking them down are, well, they're chemically mirrored, but they're achieved through entirely separate, distinct mechanisms.

Okay, let's unpack that.

Fatty acids are usually, you know, defined by their ability to store fuel, but the source material makes it clear they're so much more than just inert storage.

So, absolutely.

So what are the four major physiological roles listed that elevate them beyond just a simple, you know, a fuel tank?

The roles are, I mean, they're foundational to life itself.

The first, and the one everyone knows, is as fuel molecules.

They're stored incredibly efficiently as these neutral fats, or triacylglycerols, inside specialized cells called adipocytes.

When your body needs sustained energy, say during rest or moderate exercise, fat is the primary resource it mobilizes.

Okay, so that's number one, fuel.

Number two, they're indispensable building blocks.

Fatty acids form the core of phospholipids and glycolipids.

Which make up our cell membranes.

Every single biological membrane in the body, they provide the structural integrity and the defining properties of those membranes.

Got it.

What's third?

Third, they're crucial for protein modification.

We see them covalently attached to target proteins, and this process is essentially, it's like giving that protein an internal address label.

We make sure it goes to the right place.

Exactly.

It ensures it's correctly targeted to a specific membrane location, like the cell surface or an organelle.

Finally, number four, derivatives of fatty acids serve as potent signaling molecules.

They're messengers.

Powerful ones.

They function as local hormones and intercellular messengers,

regulating processes from inflammation and blood flow, all the way to synaptic transmission and sleep cycles.

It's a really comprehensive portfolio, but that role as fuel is truly astonishing, especially when you compare it to carbohydrates.

We always hear carbs are the quick fuel, but fat is clearly the ultimate long -term solution.

No question.

So if both pathways exist, why did evolution overwhelmingly select fat or triacylglycerols as the body's largest energy reservoir?

I mean, what trade -offs were made?

It really all comes down to maximizing energy density for survival and mobility.

Fat is just superior because of two major chemical properties.

It's reduction state and it's hydration state.

Okay, break those down.

What do you mean by reduction state?

So triacylglycerols are highly reduced.

The long hydrocarbon tails are just packed with carbon hydrogen bonds, which means they have a vast number of electrons available to release when you oxidize them.

So more electrons means more potential energy.

Precisely.

It means they are inherently more energy dense.

If you oxidize fat, you get about 38 kilojoules per gram.

Compare that to only 17 kilojoules per gram for carbohydrates.

So even on a dry weight basis, fat is already more than double the efficiency.

Exactly.

But the second factor, hydration, is arguably even more critical.

Triacylglycerols are highly non -polar, meaning they're stored almost entirely anhydrously.

They're dry.

They're dry, compact molecules.

Carbohydrates like glycogen, on the other hand, are polar and hydrophilic.

This means every gram of glycogen binds about two grams of water when it's stored in the cell.

So it comes with baggage.

A lot of baggage.

And if you combine that double energy density with the lack of water weight, a gram of anhydrous fat stores about, get this, 6 .75 times more available energy than a gram of hydrated glycogen.

6 .75 times.

That is a profound physiological difference.

So let's frame this in survival terms.

A typical, say, 70 kilogram person carries about 11 kilograms of fat, which is enough to survive for weeks.

Correct.

How much heavier would that person be if they had to carry the exact same amount of energy but only as hydrated glycogen?

You'd be carrying an extra 64 kilograms of weight.

Wow.

Yeah.

Mostly water bound to the glycogen.

The evolutionary pressure is just obvious, isn't it?

For an active organism, especially one facing famine or migration, minimizing your stored mass while maximizing your energy density is just paramount.

Fat allows for long -term survival while letting you stay mobile.

And we see that principle in action, not just in humans surviving famine, but in these incredible feats of the natural world.

Oh, absolutely.

You just have to think of migratory birds.

The American golden plover, the ruby -throated hummingbird, they undertake these prodigious nonstop migratory flights over vast oceans.

Powered by fat.

Exclusively.

They can double their body weight in fat before the journey.

And these weeks -long feats are powered almost entirely by the efficient lightweight energy reserves of stored tricylglycerols.

This system is just, it's perfectly optimized for incredible energy output.

So now that we understand why fat is the preferred storage, let's look at how the fat we eat even makes it into the body to become that reserve.

This starts with digestion, which immediately presents a unique chemical challenge.

Fat is water insoluble, but our gut is entirely aqueous.

It's the first big logistics problem.

Lipids exit the stomach as this coarse emulsion.

To solve this, we need molecular detergents.

And those are the bile acids.

The bile acids, like glycoclate, which are synthesized in the liver and secreted from the gallbladder.

These molecules are amphipathic.

They have distinct polar heads and non -tolar tails.

They coat the lipid droplets, and they effectively break that coarse emulsion down into these fine, stable micelles.

So the bile acids are critical for this emulsification step.

They make the fat soluble enough for the enzymes to actually get to them.

They create the targets.

That's the preparation phase.

The actual enzymatic breakdown is done by pancreatic lipases, which hydrolyze the triacylglycerols into free fatty acids and monoacylglycerol.

But does the lipase need help?

It does.

Even with the bile coating, the lipase needs help docking onto the fat particle.

And that assistance comes from colopase, another pancreatic product, which binds to the lipase and physically anchors it to the surface of that lipid particle, letting the degradation begin.

That's a highly coordinated effort then.

You've got bile for emulsification, colopase for anchoring, and then the lipase for the actual hydrolysis.

Correct.

And the resulting free fatty acids and monoacylglycerol then assemble into structures called micelles for absorption.

And once formed,

these mixed micelles transport the products across the unstirred water layer and into the intestinal epithelial cells, right, the mucosal cells.

That's the route.

And this is where we see a really clear clinical connection that shows just how necessary this first stage is.

Steaturia.

Exactly.

If the liver is diseased and can't produce enough bile salts, or if the flow is blocked, you lose this emulsification capability.

The result is steaturia, the excretion of large amounts of undigested fat in the feces.

The body just can't absorb what it can't solubilize.

It proves how essential those first steps are.

So once the fatty acids and monoacylglycerols are inside the mucosal cell, they need to be prepped for the journey through the bloodstream.

They were just broken down, but now they're immediately reformed, is that right?

Yes, they're swiftly resynthesized right back into triacylglycerols.

They can't just travel freely.

And since fat has to navigate the watery highway of the blood, these large hydrophobic triacylglycerols get bundled into these massive stable lipoprotein packages.

Called chylomicrons.

I always think of these as the body's largest cargo ships, built for a long voyage.

That's a great analogy.

They're essentially a stable shell made of phospholipids, cholesterol, and specific apolipoproteins like apolipoprotein B48,

and that shell surrounds a massive core of triacylglycerols.

They also act as transporters for essential fat -soluble vitamins and cholesterol.

But they're huge.

They are.

Because of their sheer size, they're too large to directly enter the capillaries leading to the blood.

So they take a detour.

They take the scenic route through the lymph system first, bypassing the immediate portal circulation before they finally enter the blood.

Then they travel through the bloodstream until they reach their destination, either muscle tissue for immediate use or adipose tissue for storage.

And how does the cargo get dropped off?

When the chylomicron reaches the target tissue, it binds to membrane -bound lipases, specifically lipoprotein lipase on the capillary walls of the muscle or adipose tissue.

These lipases degrade the triacylglycerols again, releasing free fatty acids.

They're a second breakdown.

A second breakdown.

And these fatty acids are then transported across the membrane into the or they are either stored in the adipocyte or immediately oxidized in the muscle cell.

It's this complex, energy -consuming process of breakdown, resynthesis, packaging,

transport, and then a final breakdown, just to move dietary fuel from the gut to the cell.

That handles the fat we eat.

Now let's discuss the true emergency system,

mobilizing the vast long -term reserves stored in our adipocytes.

This happens when the body needs sustained energy and blood glucose is running long -distance or fasting.

The breakdown of these stored fats or degradation happens in three rigorous stages.

And stage one is the command to burn.

It's called lipolysis.

This is entirely regulated by catabolic hormones that signal energy scarcity, mainly glucagon and epinephrine.

So these hormones bind to the 7TM receptors on the adipocyte surface.

Which sets off the classic signal transduction cascade involving cyclic AMP, and that culminates in the activation of protein kinase A.

And pKa is the molecular switch that translates that hormonal signal, we need fuel now, into the action of releasing the fat.

What are the specific targets that pKa activates?

pKa acts as a dual control swish by phosphorylating two critical proteins that are associated with the lipid droplet.

First, it phosphorylates para -lipin.

Para -lipin.

That's the protein coating the fat droplet itself.

Exactly.

You can think of para -lipin as the structural gatekeeper or like a security wrapper around the reserve.

When it gets phosphorylated, para -lipin structurally changes and it releases a critical co -activator molecule.

And that co -activator then triggers the first actual enzyme, right?

Yes.

The co -activator acts on adipose triglyceride lipase, ATGL, which kicks off the cascade by hydrolyzing the first fatty acid from the triacylglycerol, leaving a diacylglycerol.

And the second action of pKa.

The second parallel action of pKa is to directly phosphorylate and activate hormone -sensitive lipase, HSL.

HSL prefers diacylglycerol substrates, so it comes in and releases the second fatty acid, leaving a mono -islyglycerol.

The final step is managed by a separate mono -islyglycerol lipase, which releases the third and final fatty acid.

Giving you three free fatty acids and a molecule of glycerol.

A meticulously regulated three enzyme relay race.

And if that initial gatekeeper function, the co -activator for ATGL, fails.

Then you see the pathology of Channer Endorphin Syndrome.

In this rare condition, a fat can't be effectively released from the storage droplets, which results in the pathological accumulation of triacylglycerols throughout the body.

It really demonstrates that the initial step, even before the major lipases are fully active, is absolutely rate -limiting.

Once released, what are the distinct fates of the two products?

The fatty acids and the glycerol.

So the fatty acids being hydrophobic, they have to be chaperoned through the blood.

They bind tightly but non -covalently to the major blood protein albumin.

Like a taxi service.

A taxi service that transports them to distant tissues needing energy, like resting muscle or the heart.

The glycerol, on the other hand, is water soluble.

So it's absorbed primarily by the liver.

What's the liver's metabolic goal with that glycerol?

The liver converts glycerol into intermediates that are fully integrated into carbohydrate metabolism.

Glycerol is first phosphorylated, then oxidized to dihydroxyacetone phosphate, DHAP, which is then isomerized to glyceraldehyde 3 -phosphate.

Which are intermediates in both glycolysis and gluconeogenesis.

And that's the crucial part.

It means the glycerol released from fat can be used by the liver either to produce energy for itself or critically to produce new glucose to maintain blood sugar for the brain and red blood cells.

So that's mobilization.

Stage two is preparing the fatty acid for the mitochondrial furnace.

The activated fatty acid has to cross the formidable barrier of the inner mitochondrial membrane.

Stage two begins with activation on the outer mitochondrial membrane.

The fatty acid gets linked to coenzyme A, forming an acyl -CoA, a reaction catalyzed by acyl -CoA synthetase.

And this is where we pay the energy toll upfront.

Yes.

The reaction uses ATP, but it splits it into AMP and pyrophosphate, or PPI.

Why is that significant splitting to AMP instead of ADP?

Because that PPI is immediately hydrolyzed to two inorganic phosphates by pyrophosphatase.

This secondary highly exergonic hydrolysis essentially pulls the entire activation reaction forward, making it irreversible.

Metabolically, because you cleave two high -energy phosphate bonds, ATP to AMP, this step consumes the equivalent of two ATP molecules.

The one -time non -negotiable activation fee.

That's it for burning the fatty acid.

So once activated, the long -chain acyl -CoA faces the ultimate barrier, the highly impermeable inner mitochondrial membrane.

How does it cross into the matrix where the combustion machinery is?

It uses the carnitine shuttle.

Acyl -CoA can't pass through on its own.

It needs a special molecular visa, which is carnitine.

On the outer membrane, carnitine acyl -transferase I, CPTI, acts as the border guard.

It removes the CoA and transfers the acyl group onto this sweterian molecule, carnitine, creating acyl -carnitine.

So the acyl -carnitine is a transport molecule.

It is.

Acyl -carnitine is then specifically shuttled across the inner membrane by a dedicated translocase protein.

Once it's inside the matrix, the second border guard, carnitine acyl -transferase II, CPT2, transfers the acyl group back onto a molecule of coenzyme A that's already in the matrix.

Regenerating the acyl -CoA, ready for oxidation.

Right.

And it releases free carnitine, which gets returned to the outside by the translocase, ready for the next one.

That analogy of the visa and the two border guards makes the mechanism incredibly clear.

The clinical connection here must be equally profound.

Oh, it is.

Deficiencies in carnitine itself or in either of the transferases, CPTI or CPT2, severely impair the oxidation of long -chain fatty acids.

The most common symptom is muscle weakness, especially during prolonged exercise.

Why specifically, then?

Because during endurance activities, muscle relies heavily on fat for sustained fuel.

If fat can't get into the furnace, the muscle fatigues rapidly.

It's a perfect illustration of how restricted transport flow causes systemic energy failure.

So stage three is the payoff, the actual breakdown or bachization, right there in the mitochondrial matrix.

This is often described as a spiral pathway.

It is.

It's a rigorous repeating sequence of four reactions that systematically cleaves the fatty acid chain down two carbons at a time, starting at the eucarbon C3, which gives the pathway its name.

Let's walk through the four steps of one complete cycle focusing on the products that generate energy.

Okay.

Step one, FAD -linked oxidation.

The enzyme acyl -CoA dehydrogenase introduces a double bond between C2 and C3.

This yields transdynanoil CoA and one molecule of FADH.

And those FADH electrons go straight to the respiratory chain.

They do.

They enter via the ETF ubiquinone reductase complex, and they yield about 1 .5 molecules of ATP.

We use FAD here because the energy of this oxidation is lower than what's needed to reduce NADU.

Okay.

Step two is hydration, adding water.

Enoil CoA hydratase adds water across that double bond.

This step is highly stereospecific, which is a hallmark of biology.

It yields only the L3 -hydroxyacyl -CoA isomer.

Step three, NAD -linked oxidation.

L3 -hydroxyacyl -CoA dehydrogenase oxidizes the hydroxyl group to a keto group.

This produces three ketoacyl -CoA and one molecule of NADH.

This oxidation is more energetic, and the NADH goes directly to complex I of the respiratory chain, yielding about 2 .5 molecules of ATP.

And the final step, the cleavage.

Step four, phialysis.

The gate ketothiolus enzyme uses a new molecule of coenzyme A to cleave the bond between the alpha and beta carbons.

This produces one molecule of acyl -CoA and a new acyl -CoA that is now two carbons shorter.

And that shortened chain is the substrate for the next round of the four -step spiral.

Continuing until the entire fatty acid is consumed.

This elegance and repetition are why it's called a spiral.

So let's confirm the immense energy yield, using the classic example.

Palmitoyl -CoA, the activated CO -saturated fatty acid.

Okay, palmitate requires seven cycles of oxidation to be completely dismantled.

Those seven cycles produce seven FADHs and seven NADH.

And the final CO unit is cleaved in the seventh round into two acetyl -CoA molecules.

Adding the six acetyl -CoA units from the previous rounds, we have a total of eight acetyl -CoA molecules ready for the citric acid cycle.

Okay, the moment of truth.

The total ATP calculation.

The eight acetyl -CoA entering the CIA yield 80 ATP.

The seven NADH yields 17 .5 ATP.

The seven FADH yields yield 10 .5 ATP.

The total generated is 80 plus 17 .5 plus 10 .5, which equals 108 gross ATP molecules.

And after subtracting that initial activation cost of two ATP equivalents.

The net yield is a monumental 106 molecules of ATP from a single CO of fatty acid.

And that number, that's the defining metric of fat metabolism.

It shows, in stark numerical terms, why fat is the body's ultimate survival fuel and why the body dedicates such complex and distinct machinery to both store and release it.

So oxidation is perfectly tailored for these even -chain saturated fats.

But the fats we eat, they rarely conform to that standard.

We ingest unsaturated fats with double bonds or wear odd -chain fats.

How does the body handle these interruptions to that standard four -step cycle?

The system shows this incredible metabolic economy.

It only requires a small suite of accessory enzymes to manage these deviations.

It avoids having to develop entirely new pathways.

So let's start with mono -unsaturated fats.

A single double bond can derail the bi -oxidation tray.

It does because the sequence is built to oxidize a saturated chain and handle the resulting trans -double bond at C2.

If, after a few rounds, the machinery encounters a double bond at C3 in the cis configuration, which is common in natural fats, the standard hydrotase enzyme just can't process it.

So what's the fix?

The fix needs just one enzyme.

Cis -noyl -CoA isomerase.

This enzyme simply shifts the double bond from the cis -C3 position to the trans -C2 position.

The resulting molecule is a perfect substrate for the next standard oxidation step.

So one simple chemical maneuver and isomerization is enough to salvage the whole process.

Exactly.

The pathway continues.

What about the more complex case of poly -unsaturated fats with multiple double bonds?

This requires a slightly more expensive patchwork.

It needs two accessory enzymes.

The first is the same isomerase we just talked about, but further rounds of oxidation might generate a 2 -philimphor -dienoyl intermediate.

Meaning double bonds at C2 and C4 simultaneously.

Right.

And the standard pathway just cannot proceed past this point.

This is where 2 -philimphor -dienoyl -CoA -reductase steps in.

That name suggests it reduces one of the double bonds.

It does.

Using NADPH, it reduces that 2 -philimphor -dienoyl intermediate to a single cis -double bond, consuming one NADPH.

Now, the resulting molecule is in a form that the original isomerase can handle, shifting it to the standard transom position and bauxidation can resume.

It's a beautifully layered solution.

Moving to odd chain fatty acids, they run the normal bauxidation spiral until the very last turn, which leaves a C remnant instead of acetyl -CoA.

And that 3 -carbon remnant is propionyl -CoA.

Since it can't be broken down further by bauxidation, the body employs a dedicated pathway to salvage these 3 carbons by converting them into an intermediate of the citric acid cycle.

Specifically, cis -cynyl -CoA.

Exactly.

This conversion takes three steps, starting with propionyl -CoA carboxylase.

Which is a biotin -dependent enzyme.

Right.

It uses ATP to add a carbon dioxide group, producing demethamolonyl -CoA.

This is followed by a racemase to switch it to the L isomer.

And the final step, the conversion of l -methamolonyl -CoA to succinyl -CoA is one of the most mechanically fascinating reactions in all of biochemistry.

Because it requires the rare player, vitamin -bio -Cobamen.

Tell us about the structural element that makes this bio -mechanism so unique.

So, vitamin -beros contains a corrin ring structure surrounding a central cobalt atom, usually CoA.

This enzyme, methyl -methamolonyl -CoA -mutex, has to catalyze an intramolecular rearrangement, swapping a hydrogen atom and a bulkier group on adjacent carbons.

A difficult chemical task.

Very.

And to achieve it, the coenzyme has to perform this highly unusual reaction initiation, homolytic cleavage of the cobalt -carbon bond.

Homolytic cleavage means the bond breaks evenly, with one electron remaining on each side, forming a highly reactive free radical.

That's generally a toxic, unstable state in biological systems.

Precisely.

The transient creation of the highly reactive 5 -deoxydenosyl radical is the essential powerful move here.

This radical then abstracts a hydrogen atom from the substrate, creating a substrate radical.

This radicalized substrate spontaneously rearranges before the intermediate radical abstracts a hydrogen back from the 5 -deoxydenosine to finish the cycle and form succinyl CoA.

The necessity of generating a free radical, even briefly, highlights the difficulty of the task.

It really does.

It shows the effort the body makes not to waste any fuel turning this propionyl CoA remnant into a usable CAC intermediate.

That really drives home the effort.

Now, let's briefly acknowledge a secondary site of oxidation, the peroxisomes.

We associate degradation primarily with mitochondria, so what specific job do peroxisomes handle?

Peroxisomes are metabolic prepstations.

They handle very long -chain fatty acids, things longer than 20 carbons.

They perform oxidation cycles just to shorten these chains until they're short enough, usually CO, to be transported to the mitochondria for final, complete oxidation.

And their process is fundamentally different in the first step.

Yes.

In the mitochondrial process, FADHROS enters the ETC to generate ATP.

In the peroxisome, the initial dehydrogenation enzyme transfers electrons directly to molecular oxygen, OO, producing hydrogen peroxide, ATROS, instead of capturing energy.

And the peroxisome contains high levels of catalase to rapidly degrade that peroxide.

It does.

The consequence is that the energy released from the initial shortening of these very long chains is dissipated as heat, not efficiently captured as high -potential electrons.

A malfunction here, like in Vellweger syndrome, means those very long -chain fatty acids build up pathologically.

It's a failure of transport and preprocessing, leading to severe neurological and systemic disease.

Okay.

Let's pivot to the major consequence of overwhelming fatty acid degradation,

the formation of ketone bodies.

This brings us to that famous statement.

Fats burn in the flame of carbohydrates.

What is the exact metabolic reason for this connection?

The connection lies in the citric acid cycle.

The acetyl -CoA generated by fat oxidation can only enter the CAC by condensing with oxaloacidate, OAA.

If carbohydrate supply is low, which happens during fasting, very low -carb diets or, crucially, an uncontrolled type 1 diabetes OAA is massively diverted away from the sepoe and into gluconeogenesis to produce glucose, which is essential for survival.

So if OAA levels drop because it's being pulled to make sugar, the huge flood of acetyl -CoA coming from fat breakdown gets trapped inside the mitochondrial matrix.

Exactly.

It's a traffic jam.

This trapped acetyl -CoA is converted into ketone bodies in the liver, a process called ketogenesis.

The three primary ketone bodies are acetoacetate, D3 -hydroxybutyrate, and the volatile, spontaneously -produced byproduct, acetone.

What purpose do these ketone bodies serve?

They're a highly valuable, water -soluble, transportable form of acetyl units.

Instead of trying to transport the insoluble fatty acids everywhere, the liver converts them into these small soluble molecules, which diffuse into the blood and are consumed by peripheral tissues like the heart, kidney, and, critically, the brain.

The brain is usually so dependent on glucose, but starvation changes that.

The brain is highly adaptable.

During prolonged starvation, the brain can gradually increase its consumption of ketone bodies to satisfy up to 75 % of its total fuel needs, thereby reducing the reliance on limited glucose reserves.

And the liver itself is an interesting paradox here.

It is.

The liver is the factory, the major site of synthesis, but it's not a consumer.

The liver lacks the specific CoA transferase enzyme required to activate acetoacetate back into acetyl CoA for use.

So it makes them solely to export them as fuel for the rest of the body.

Correct.

This mechanism, pushed into overdrive, leads to the dangerous state of diabetic ketoacidosis.

In severe, untreated diabetes, the fundamental problem is an absence of insulin signaling.

This causes two simultaneous failures.

High rates of fatty acid mobilization, since fat cells are constantly told to release fuel, and very low OAA levels, since OAA is diverted to gluconeogenesis.

A perfect storm.

The liver processes these massive fatty acid loads into massive amounts of ketone bodies.

Since acetoacetate and D3 -hydroxybutyrate are moderately strong acids, their overproduction rapidly lowers the blood pH, causing severe acidosis, which disrupts the central nervous system, leading to coma and tissue failure.

Before moving to synthesis, we have to fully address this point about the glucose barrier.

We rely on fat for survival fuel.

We see the elaborate mechanism of ketogenesis.

But why can't animals simply convert fat directly into glucose?

This is a foundational constraint of animal metabolism.

The reaction that creates acetyl CoA from pyruvate, catalyzed by pyruvate dehydrogenase, is irreversible.

You cannot run it backward to make pyruvate from acetyl CoA.

Furthermore, while acetyl CoA enters the citric acid cycle, the two carbons it introduces are balanced by two carbons lost as CoO further down the cycle before oxalacetate is regenerated.

There is zero net synthesis of OAA or any other gluconeogenic intermediate from the acetyl unit of fat in animals.

It's a metabolic one -way street.

The carbons of fat can burn brilliantly, but they cannot refill the glucose tank directly.

It forces that detour through ketone bodies, which is efficient but requires adaptation and, as we noted, becomes dangerous if the system is overloaded.

And finally, a quick health warning regarding trans fats.

Right.

When vegetable oils are artificially hydrogenated to increase shelf life, it generates saturated and trans -unsaturated fatty acids.

The epidemiological evidence is compelling.

High consumption of these processed fats is strongly correlated with inflammation, obesity, type 2 diabetes, and atherosclerosis.

The metabolic machinery is just not built to handle these modified structures effectively.

Okay.

We've spent considerable time on how the body lights the fire.

Now let's pivot to how it stockpiles the wood, the process of fatty acid synthesis.

We begin by noting that synthesis and degradation are chemically mirrored but mechanistically distinct.

Let's formally lay out those six crucial differences, as they are the keys to regulation.

Understanding the separation is essential for understanding metabolic control.

First, location.

Synthesis is in the cytoplasm.

Degradation is in the mitochondrial matrix.

That spatial separation immediately ensures independent control.

Second, a cell carrier.

In synthesis, intermediates are held by the acyl carrier protein, ACP, which functions as a molecular scaffold.

In degradation, they're linked to coenzyme A, COA.

Different handles for the molecules.

Different handles.

Third, enzyme structure.

In mammals, synthesis is carried out by a single massive multifunctional protein complex, fatty acid synthase, FAS.

Degradation uses individual, separate enzymes.

Okay, that's a big one.

Fourth.

Fourth, the activated donor.

The active two -carbon donor unit that builds the chain is melonal ACP.

The unit removed during degradation is acetyl -CoA.

Number five.

Five, reductant oxidant.

Synthesis is a reduction requiring high -energy electrons from NADPH.

Degradation is an oxidation generating high -energy electrons for the ETC via NADO and FAD.

And the last one, number six.

And sixth, stereochemistry.

The hydroxyl intermediate formed during synthesis is the D isomer.

The intermediate in degradation is the L isomer.

That structural and functional separation is elegant and prevents the body from running a futile cycle where it simultaneously builds and tears down fat.

The precursor is acetyl -CoA.

But the committed, irreversible starting step for synthesis is the creation of that two -carbon donor unit, melonal -CoA.

Acetyl -CoA is carboxylated to melonal -CoA, catalyzed by the cytoplasmic enzyme acetyl -CoA carboxylase 1, ACC1.

It's a classic biotin -dependent reaction requires ATP.

This step is the regulatory cornerstone of the entire synthesis pathway.

And once melonal -CoA is formed, the intermediates are immediately transferred and covalently linked to the ACP arm of the fatty acid synthase complex.

That's right.

So let's look at the actual building cycle, the fatty acid synthase cycle.

Ah.

It starts with an acetyl -CoA primer and then uses melonal -CoA as the steady two -carbon donor.

The FAS complex first loads the acetyl primer onto one site and the melonal donor onto the ACP arm.

The key reaction is condensation, where the acetyl unit condenses with the melonal unit

And that release of CoA is not waste, it's the thermodynamic engine of the reaction.

Explain that.

Although bicarbonate was used to make melonal -CoA in the first place, that same carbon is immediately released as CoA in this condensation step.

This decarboxylation provides a massive favorable drop in free energy, making the condensation reaction thermodynamically irreversible and highly favorable.

It drives the entire synthesis forward.

So it's critical to remember that all the final carbons in the fatty acid originate from acetyl -CoA.

The CoA is just a temporary metabolic handle.

A temporary handle to provide the energy push.

So after condensation, we have a C or O -ketoacyl group and the goal is to fully reduce that back to a saturated chain.

This reduction phase is three steps, the reverse of oxidation.

It's the reverse chemistry but with different enzymes and a different electron donor.

First, reduction one.

B -ketoacyl reductase uses NADPH to reduce the keto group to a hydroxyl group, specifically generating the de -isomer.

Opposite to the L -isomer in degradation.

Right.

Second, dehydration.

Three -hydroxyl dehydrotase removes water, creating a double bond.

And third, reduction two.

Eno -hydro -reductase uses a second molecule of NADPH to reduce the double bond, resulting in a saturated acyl -ACP.

A C -utyl -ACP in the first cycle.

This C -uro then acts as the new primer, condensing with a fresh malonyl -ACP and the cycle repeats.

It repeats six more times.

After seven total cycles, the C -uro product, palmitoyl -ACP is formed.

A separate domain on the FAS complex, the thioesterase, acts as a molecular ruler.

A ruler.

It recognizes the C -uro link and hydrolyzes the palmitoyl -ACP to release free palmitate, regenerating the FAS complex for the next round.

The machinery itself is remarkable.

In mammals, FAS is not a loose collection of enzymes, but this massive multifunctional complex.

It's a gigantic dimer of identical polypeptide chains.

And this structure creates organizational efficiency, dividing the labor into two main functional compartments.

You have the selecting and condensing compartment, which manages the initial substrate binding and the condensation.

And then you have the modification compartment, which handles the three reduction and dehydration steps.

And this architecture ensures intermediates are never released into the cytoplasm.

Maximizing efficiency and preventing site reactions.

This sophisticated arrangement likely evolved through the fusion of genes that previously coded for separate single -function enzymes.

Now we have to address the logistics paradox again.

Acetyl -CoA is the carbon source, but it is made inside the mitochondria.

Yet synthesis occurs in the cytoplasm.

How do we ferry this key building block across the mitochondrial boundary?

We use the citrate shuttle.

Acetyl -CoA cannot cross directly.

Instead, it combines with OAA in the mitochondrial matrix to form citrate.

When the cell is in an energy replete state, citrate levels are high, and citrate is specifically transported out into the cytoplasm.

And once it's outside, the acetyl -CoA is regenerated.

Yes.

In the cytoplasm, ATP citrate lyase cleaves citrate back into acetyl -CoA, the synthesis substrate, and OAA, which has to be recycled.

This cleavage is stimulated by insulin, signaling abundance, and crucially, it costs one molecule of ATP.

So we've transferred the acetyl group, but we have this OAA remnant in the cytoplasm.

How is that OAA efficiently recycled back into the mitochondria, and how does this process relate to the high demand for NADPH?

This recycling loop is ingenious because it simultaneously recycles the OAA and generates most of the required NADPH.

The OAA is first reduced to malate.

Then, the key enzyme, malic enzyme, oxidatively decarboxylates malolate into pyruvate, and this reaction generates one molecule of NADPH.

And the pyruvate then easily re -enters the mitochondria.

Where it can be carboxylated back to OAA via pyruvate carboxylase, completing the cycle.

That means for every upsettle CoA transferred out, we get one molecule of NADPH generated by the recycling loop.

Since palmitate synthesis requires 14 NADPH molecules, and we transfer 8 acetyl CoAs, this recycling provides 8 of them.

Exactly.

The remaining 6 NADPH molecules needed for palmitate synthesis come from the pentose phosphate pathway.

And this pathway integration is profound.

Sympathesis requires coordinated input from the cax, specific transport systems, the pentose phosphate pathway, glycolysis, and oxidative phosphorylation.

All cellular energy production has to be running smoothly.

Let's dedicate some time to the major clinical implication of this pathway.

Its role in cancer and obesity.

The source material notes that cancer cells rely on increased de novo fatty acid synthesis.

They do.

Cancer cells are characterized by high proliferation rates and high demand for membrane components.

The fatty acids synthesized by FAS are rapidly incorporated into phospholipids for new cell membranes.

And furthermore, fatty acid derivatives are used as signaling molecules that promote cell growth.

So many FAS pathway enzymes are overexpressed in fast -growing tumors.

Creating a metabolic vulnerability.

This means the synthesis pathway becomes a strong therapeutic target.

Inhibitors of the pathway, specifically targeting key enzymes like Futo AC, ACP synthase,

and acetyl -CoA carboxylase, are being developed.

And by inhibiting fatty acid synthesis, you starve the cancer cell of the building blocks it needs for membrane expansion.

And you disrupt its pro -growth signaling, which induces apoptosis or programmed cell death.

And the unexpected link to obesity that was observed in animal models.

It's fascinating.

When mice were treated with these FAS inhibitors, researchers saw significant weight loss because the animals drastically reduced their food intake.

This suggests that these synthesis pathway inhibitors may not only function as anti -tumor agents, but could also hold potential as novel anti -obesity drugs by modulating appetite control systems.

It's a fascinating crossover application for an enzyme we primarily associate with energy storage.

So fatty acid synthase builds up to palmitate, CER, but the body requires much longer chains, like CERO, and it needs double bonds.

Where do these final modifications occur?

These modifications happen outside the FAS complex, primarily on the endoplasmic reticulum ER membrane.

Elongation occurs here by sequentially adding two carbon units to the carboxyl end of the pre -existing fatty acyl -CoA substrate, still using malonyl -CoA as the donor.

And the process of introducing double bonds desaturation is also an ER function.

Correct.

The mechanism is complex.

It requires molecular oxygen, NADH or NADPH, and a three -protein system embedded in the ER membrane, including the steroyl -CoA desaturase enzyme.

For example, converting steroyl -CoA to oleoyl -CoA involves inserting a single ciso double bond.

This brings us to a major metabolic limitation in mammals.

We can insert some double bonds, but there is a line we cannot cross.

And that line is at carbon 9.

Mammals lack the enzymes necessary to introduce double bonds beyond C9, that is, further toward the methyl or omega end of the chain.

This inability defines the essential fatty acids.

We must get them from our diet.

We must obtain linolea and linolein A3 from the diet, as they are necessary precursors for synthesizing longer, highly important polyunsaturated fatty acids.

And one of the most critical of those derivatives is arachidonate.

Arachidonate is a 20 -carbon, four -double bond fatty acid derived from dietary linoleate.

It serves as the direct precursor for a large, important class of regulatory molecules known as the eicosanoids.

Named for their 20 -carbon length.

What are the primary types of eicosanoids, and what is their functional signature?

The main classes include prostaglandins, which have a unique five -carbon ring structure, prostacyclines, thromboxanes, and leukotrienes.

Their defining function is that they act as extremely potent local hormones.

Meaning they act nearby and for a short time.

They're synthesized, released, and quickly metabolized, acting only on the cell that produced them, or on immediately adjacent cells to regulate acute processes like inflammation,

smooth muscle contraction, blood clotting, and even fever response.

This pathway is the perfect place to discuss the mechanism of a common drug, aspirin.

Aspirin, or acetylsalicylic acid, works by specifically and irreversibly blocking prostaglandins synthase, which is also called cyclooxygenase, or COX.

It does this by acetylating a serine residue in the active site of the enzyme.

And since that enzyme is the very first step in converting arachidonate into these signaling precursors.

Blocking it interferes with the synthesis of all prostaglandins, prostacyclines, and thromboxanes.

This single molecular mechanism explains its wide -ranging pharmacological effects,

anti -inflammatory, pain relieving, fever reducing, and critically antithrombotic.

Finally, the source places fatty acid synthase into a broader category of incredible biological machinery.

Yes, FAS is part of the megacynthase family.

These are huge modular complexes, often found in microbes, that synthesize incredibly complex natural products.

This family includes the machinery responsible for creating powerful antibiotics like erythromycin and penicillin.

Studying the structural logic of FAS gives us crucial insight into how nature builds these highly complex specialized molecules.

We have established that synthesis and degradation are physically and mechanistically separate.

To ensure metabolic efficiency, they must be strictly controlled so that both are not simultaneously active.

We don't want a fetal cycle burning up ATP needlessly.

This requires reciprocal regulation.

And the control switch is firmly planted at the committed step of synthesis,

acetyl -CoA carboxylase.

ACC is regulated by three layers, local allosteric signals, covalent modification like phosphorylation, and global hormonal signaling.

We should also remember it exists in two key isozymes, ACC1 in the cytoplasm, which controls synthesis, and ACC2 on the mitochondria, which primarily controls degradation.

Let's start with the covalent modification by phosphorylation, which acts as the immediate cellular energy sensor.

ACC is active when it's dephosphorylated and inactive when it's phosphorylated.

The enzyme responsible for the inactivation switch is AMP -activated protein kinase, AMPK.

The cell's ultimate fuel gauge.

That's it.

It's activated by high levels of AMP, which signals a low energy state.

So when the cell is starved, AMPK is on, it phosphorylates ACC, and this immediately switches off fatty acid synthesis.

So low energy equals synthesis off.

What about local allosteric control based on available raw materials?

The primary allosteric activator is citrate.

When citrate is high, meaning there's plenty of acetyl -CoA being produced in the mitochondria and successfully exported, it signals energy and abundance.

High citrate stimulates ACC by causing inactive ACC dimers to polymerize into these long active filaments.

And importantly, high citrate can even partially override the inhibitory effects of phosphorylation.

It can.

Conversely, the product itself, palmitoyl -CoA, is the allosteric inhibitor.

When palmitoyl -CoA levels are high, it causes the active filaments of ACC to disassemble back into inactive dimers, turning the synthesis machinery off.

It's a comprehensive negative feedback loop.

Now let's bring in the most elegant piece of this regulation, the product of ACC, melano -CoA.

This links synthesis directly to the inhibition of degradation.

This is the genius of reciprocal control.

Melano -CoA is not just the two -carbon donor.

It is also a potent allosteric inhibitor of carnitine acetyltransferase I, CPTI, the key enzyme responsible for ferrying fatty acids into the mitochondrial matrix for degradation.

So when ACC is active and producing melano -CoA, in other words, when synthesis is on, the resulting high melano -CoA levels slam the gate shut on the carnitine shuttle.

Exactly.

This prevents any newly synthesized fatty acids or even free fatty acids arriving from the blood from being immediately shipped back into the mitochondria to be degraded.

This is particularly crucial in tissues like the heart and muscle, which rely heavily on fat for energy but perform very little synthesis.

So in those cells, the mitochondrial isozyme, ACC2, produces melano -CoA solely as a metabolic stop signal for CPTI.

It's just regulating fuel flow, even when synthesis itself isn't the primary function.

Finally, how do global hormones coordinate this entire system?

The hormones dictate the overall physiological state feast or famine.

During fasting or exercise, you have glucagon and epinephrine.

These are catabolic signals.

They enhance PKA and AMPK activity, keeping ACC fully phosphorylated and inactive.

Synthesis is off.

And during feasting?

During feasting, you have insulin.

It signals glucose abundance.

It stimulates synthesis by activating a protein phosphatase that quickly dephosphorylates and activates ACC.

Insulin also works globally to inhibit the hormonal cascade that mobilizes fatty acids from adipose tissue.

And beyond these acute signals, the source mentions the body's long -term adjustment mechanism.

That's adaptive control.

If you maintain a diet for several days, say a high -carbohydrate, low -fat diet, the body doesn't just rely on phosphorylation, it changes the actual concentration of the enzymes.

Insulin and glucose stimulate the long -term synthesis of key enzymes like ACC and fatty acid synthase, ensuring the body is fully equipped for sustained fat storage.

What a detailed journey through the body's ultimate survival chemistry.

We started with a simple hydrocarbon chain and ended up charting the full reciprocal regulation of the entire energy system.

Our key takeaways really reinforce the sheer efficiency and complexity required to manage high -density fuel.

First, fats are the dominant energy store because of their reduced and anhydrous state, and they're mobilized via a tightly controlled pKa cascade involving ATGL, HSL, and paralypin.

Second, degradation, or v -oxidation, is a massive ATP generator.

It requires activation, which caused two ATP equivalents, transport via the carnitine shuttle, and it yield 106 net ATP from palmitate through that returning four -step cycle involving FADH -ros and NADH.

Third, synthesis is the opposite.

It occurs separately in the cytoplasm.

It's driven by the decarboxylation of malonyl CoA, requires the acyl carrier protein, and relies heavily on NADPH supplied by the citrate shuttle and the pentose phosphate pathway.

Finally, the entire balance is managed by that genius metabolic traffic light, acetyl CoA carboxylase, ACC.

It's switched off by low energy from AMPK and glucagon, and it's switched on by abundance signaled by insulin and citrate.

Its product, malonyl CoA, simultaneously ensures degradation is halted by jamming the carnitine shuttle.

And we finish today with the provocative thought we raised earlier.

Why has evolution maintained that hard, irreversible barrier preventing animals from converting fat directly into glucose?

The two carbons entering the CAC via acetyl CoA are lost as CoA.

Yet, in starvation, the brain, our most glucose -demanding organ, adapts to thrive on ketone bodies derived from that same fat.

So what does the maintenance of this strict one -way metabolic street tell us about the fundamental physiological priorities and constraints of mammalian life?

It forces this complex, high -risk detour via ketogenesis rather than a simple, direct carbohydrate synthesis.

A profound metabolic question to leave you with.

Thank you for joining us for this deep dive into the intricacies of fatty acid metabolism.

Thank you.

We'll catch you next time for more insights into the science that shapes our world.